
Alunbrik Tablets 30 mg (Brigatinib)
30mg
Tablet · Prescription medication
Takeda Pharmaceutical Company Limited
Brigatinib is an antineoplastic agent that inhibits the growth of specific cancer cells.
MFDS ingredient code M265550
Brigatinib is a targeted therapy antineoplastic, primarily used for the treatment of non-small cell lung cancer. This ingredient blocks the activity of specific proteins within cancer cells, inhibiting cancer cell proliferation.
Brigatinib interferes with the growth and division process of cancer cells by blocking the activity of specific enzymes on the surface of cancer cells. This prevents cancer cells from proliferating further, leading to a reduction in tumor size.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other antineoplastic agents, Brigatinib selectively acts on cancer cells with specific genetic mutations. This allows for effective targeting of cancer cells while reducing side effects.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
3 total

30mg
Tablet · Prescription medication
Takeda Pharmaceutical Company Limited

90mg
Tablet · Prescription medication
Takeda Korea Pharmaceutical Co., Ltd.

180mg
Tablet · Prescription medication
Takeda Pharmaceutical Company Limited
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.